Luye Pharma Group Ltd (LUP) — Capital Reinvestment Ratio
Latest as of June 2021:
1.01x
Luye Pharma Group Ltd (LUP) has a Capital Reinvestment Ratio of 1.01x as of June 2021, meaning it reinvests 1% of its operating cash flow (€274.59 Million) in capital expenditures (€278.10 Million). See Luye Pharma Group Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.01x
Capex / Operating Cash Flow
Operating Cash Flow
€274.59 Million
EUR
Capital Expenditures
€278.10 Million
EUR
Data as of
Jun 2021
Most recent filing
Luye Pharma Group Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Luye Pharma Group Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Luye Pharma Group Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Luye Pharma Group Ltd from 2016 to 2025. For live market cap and broader valuation context, see Luye Pharma Group Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | €1.78 Billion | €1.00 Billion | ▼ -94.5% |
| 2024 | 10.18x | €167.76 Million | €1.71 Billion | ▲ +1294.4% |
| 2023 | 0.73x | €1.60 Billion | €1.17 Billion | ▲ +3.8% |
| 2022 | 0.70x | €1.65 Billion | €1.16 Billion | ▼ -76.9% |
| 2021 | 3.05x | €182.37 Million | €556.20 Million | ▲ +354.9% |
| 2020 | 0.67x | €1.03 Billion | €692.81 Million | ▼ -4.6% |
| 2019 | 0.70x | €1.42 Billion | €999.34 Million | ▲ +0.9% |
| 2018 | 0.70x | €1.05 Billion | €728.16 Million | ▲ +32.3% |
| 2017 | 0.53x | €964.10 Million | €507.32 Million | ▼ -2.4% |
| 2016 | 0.54x | €592.03 Million | €319.14 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow